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Abstract
Five new highly oxygenated oplopane sesquiterpenes, songaricalarins A–E (1–5), and two known
analogues (6 and 7) were isolated from the roots and rhizomes of Ligularia songarica. Their
structures and configurations were elucidated by spectroscopic methods, including 2D-NMR
techniques, and the structure of 1 was confirmed by single-crystal X-ray diffraction. All
compounds were evaluated for in vitro cytotoxic activity against cultured A-549, MCF-7, KB, and
KBVIN cells, and 4 exhibited cytotoxicity with EC50 values of 4.9, 0.8, 3.4, and 3.2 µg/mL,
respectively.
Ligularia songarica (Fisher) Y. Ling (Asteraceae) is distributed widely in the Altaica
mountains of mainland China, and its roots and rhizomes are used as a folk medicine in the
Xinjiang region, for easing breathing, stimulating blood flow, reducing inflammation,
stopping coughs, and eliminating phlegm.1 In prior investigations, triterpenes, sterols, and
bisabolane and eremophilane sesquiterpenes have been reported.2–4 As part of our program
to discover anticancer agents from Chinese herbs, a phytochemical investigation on this
plant led to the isolation and characterization of five new oplopane sesquiterpenes (1–5) and
two known analogues 7β-[(3'-ethylcrotonoyl)oxy]-1α-[(2'-methylbutanoyl)oxy]-3,14-
dehydro-E-notonipetranone (6)5 and (3S,4R,5S,6R,7S,9R,11S,14S)-14α-acetoxy-7-[(4-
acetoxy-4-methylsenecioyl)oxy]-6-[(2- methylbutanoyl)oxy]-11,12-epoxyoplop-8(10)-en-2-
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one (7).6 Herein, we report the isolation and structure elucidation of the new compounds, as
well as the in vitro cytotoxicity evaluation of all isolates obtained against human lung
carcinoma (A-549), human breast adenocarcinoma (MCF-7), epidermoid carcinoma of the
nasopharynx (KB), and vincristine-resistant nasopharyngeal (KBVIN) cell lines.
RESULTS AND DISCUSSION
An EtOH extract of the roots and rhizomes of L. songarica was suspended in H2O and
partitioned successively with petroleum ether, EtOAc, and n-BuOH. Repeated column
chromatography of the combined EtOAc and petroleum ether portions on silica gel and C18
RP columns, followed by preparative TLC, yielded five new (1–5) and two known (6 and 7)
oplopane sesquiterpenes.
Compound 1 was obtained as colorless plates. The HRESIMS gave m/z 545.2725 [M+Na]+,
in accordance with the molecular formula, C28H42O9Na. The IR spectrum showed
absorption bands for OH (3485 cm−1), ester carbonyl (1712 cm−1), and double bond (1646
cm−1) moieties. The 1H and 13C NMR spectra (Tables 1 and 2) displayed characteristic
signals for an acetoxy group [δH 1.91 (3H, s); δC 170.5 (C), 21.2 (CH3)], a (2-
methylbutanoyl)oxy (OMebu) group [δH 2.45 (1H, m), 1.52, 1.84 (2H, m), 0.93 (3H, t, J =
7.3 Hz), 1.18 (3H, d, J = 7.3 Hz); δC 175.7 (CO), 41.9 (CH), 26.9 (CH2), 11.9 (CH3), 16.2
(CH3)],7 and a (4-methylsenecioyl)oxy (OMesen) group [δH 5.66 (1H, brs), 2.15 (2H, q, J =
7.3 Hz), 1.02 (3H, t, J = 7.3 Hz), 2.11 (3H, s); δC 166.1 (CO), 115.6 (CH), 161.9 (C), 34.1
(CH2), 12.2 (CH3), 18.6 (CH3)],8 in accordance with the significant EIMS fragment peaks at
m/z 408 [M–MesenOH]+, 348 [408–AcOH]+, and 306 [408–MebuOH]+. Apart from these
three ester groups, the NMR spectra of 1 showed resonances for an olefinic methylene [δH
5.19, 5.30 (2 × brs, 1H each); δC 114.2 (CH2), 141.8 (C)] and an epoxide [δH 2.65, 2.80 (d, J
= 3.9 Hz, 1H each); δC 53.6 (CH2), 56.9 (C)]. Moreover, the NMR signals indicated nine
CH (including five oxygenated methines), and two Me groups, in which one [δH 1.32 (s); δC
16.8 (CH3)] was attached to a tertiary C-atom and the other [δH 1.48 (d, J = 6.8 Hz); δC 16.8
(CH3)] to a secondary C-atom. To accommodate an index of hydrogen insufficiency of
eight, compound 1 was proposed as having a bicyclic sesquiterpene skeleton, with an epoxy
group and an exocyclic C=C bond, in agreement with an oplopanoid sesquiterpene
skeleton.9
The 1H and1H-COSY NMR analyses showed clear signals for the partial structure shown in
Figure 1, which was supported further by the following HMBC correlations: H-3 with C-2,
C-4, C-5, and C-14; H-4 with C-3, C-5, and C-9; H-9 with C-2, C-4, and C-8; H-10 with
C-7, C-8, and C-9 (Figure 1). These data confirmed that 1 is an oplopanol derivative. The
positions of the two hydroxy groups at C-1 and C-6 were indicated by the following HMBC
correlations: H-2, H-4, and OH (δH 3.37) with C-1, as well as H-5, H-7, and OH (δH 4.11)
with C-6. The positions of the three ester groups at C-14, C-2, and C-7 were inferred from
the HMBC correlations between H-14, H-2, and H-7 (δH 5.17, 5.25, 5.48, respectively) with
the ester C=O resonances at δC 170.5, 175.7, and 166.1 of the OAc, OMebu, and OMesen
groups, respectively (Figure 1).
The relative configuration of 1 was deduced by analysis of the 1H-1H coupling constants and
ROESY correlations. When H-4 is assumed to be in a β–orientation, H-3, H-9, and H-5
should be α-axial due to the large 3J4,3, J4,5, and J4,9 (12.6 Hz) coupling constants.
Furthermore, J6,5 and J6,7 (10.2, 2.9 Hz, respectively) indicated that H-6 and H-7 are on the
same side of the molecule as H-4, while J2,3 and J2,1 (3.9, 3.4 Hz, respectively) indicated
that H-2 and H-1 are on the opposite side from H-4. Finally, a ROESY correlation of H-4
with H-13 revealed that H-13 is located on the same side as H-4 (Figure 1). Based on the X-
ray crystallographic data (Figure 2), the orientation of the OAc group at C-14 is α. The
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absolute configuration of 1, i.e., (1S,2R,3S,4S,5S,6R,7S,9R,11S,14S), was deduced by
circular dichroism (CD) spectroscopy, in which a negative Cotton effect was observed at
358 nm (Δε−22).10 Therefore, 1 was established as (1S,2R,3S,4S,5S,6R,7S,9R,11S,
14S)-14α-acetoxy-1,6-dihydroxy-2-[(2-methylbutanoyl)oxy]-7-[(4-
methylsenecioyl)oxy]-11,12-epoxyoplop-8(10)-ene,11 and given the name songaricalarin A.
The HRESIMS of compound 2 displayed a [M+Na]+ signal at m/z 487.2457, in accordance
with the molecular formula, C25H36O8Na. Based on comparison of the EIMS and NMR
spectra of 2 (Tables 1 and 2) with those of 1, one OH and the OMebu group in 1 were
replaced by H and AcO groups, respectively, in 2. The only hydroxy group in 2 was
positioned at C-6 due to the HMBC correlations of H-5 and H-7 with C-6 (δC 74.1). The
positions of the three ester groups at C-14, C-2, and C-7 were inferred from the HMBC
correlations between H-14, H-2, and H-7 (δH 5.11, 5.50, 5.57, respectively) with the ester
C=O resonances at δC 170.3, 170.6, and 165.9 of the two OAc and OMesen groups,
respectively. The absolute configuration of 2 (songaricalarin B), i.e., (2R,3S,4S,5S,6R,7S,
9R,11S,14S), was deduced from a negative Cotton effect at 357 nm (Δε−12) in the CD
spectrum.10
Compound 3 was obtained as colorless gum. The HRESIMS showed a [M+Na]+ signal at m/
z 619.2651, in accordance with a molecular formula of C31H45O9ClNa. In addition, a series
of characteristic isotopic fragment peaks in the EI mass spectrum of 3 with a ratio of 3:1 at
m/z 229/231 and 201/203, supported the presence of a chlorine atom.12 Comparison of the
NMR spectra of 3 (Tables 1 and 2) with those of the known compound 65 showed initially
that the signals for an exocyclic C=C bond were absent, and were replaced by those for a
CH2-Cl group [δH 3.55, 3.92 (each 1H, brd, J = 11.9 Hz); δC 73.0 (C), 48.5 (CH2)], and an
OH group [δH 2.60], which was connected to C-8 as indicated by the HMBC correlations
between H-10 and OH (δH 2.60) with C-7, C-8, and C-9 (Figure 1). Second, a methyl group
in 6 was replaced by an epoxide [δH 2.59, 2.81 (d, J = 4.4 Hz, 1H each); δC 51.8 (CH2), 56.2
(C)] in 3, with the location inferred from the HMBC correlations of H-12 with C-5, C-11,
and C-13 and of H-13 with C-5, C-11, and C-12 (Figure 1). The positions of the three ester
groups, located at C-1, C-6, and C-7, were determined from the HMBC correlations of H-1
and H-6 (δH 5.28, 5.45, respectively) with the ester C=O resonances at δC 175.3 and 175.7,
respectively, of the two OMebu groups and of H-7 (δH 5.39) with the ester C=O resonance
at δC 164.3 of the OMesen group (Figure 1).
The relative configuration of 3 was deduced by analysis of the 1H-1H coupling constants and
ROESY correlations. The coupling constants J4,9, J4,5, J10a,10b, and J5,6 (all ca. 11.9 Hz), as
well as J1,9 and J6,7 values of 4.7 Hz and 3.1 Hz, respectively, in the 1H NMR spectrum,
together with the cross-peaks between H-9 and OH, H-4 and H-13, H-4 and H-6, and H-6
and H-7 in the ROESY spectrum, indicated that H-4, H-6, H-7, and H-10 are trans-oriented
with respect to H-9, H-1, H-5, and OH (Figure 1). The absolute configuration of 3, i.e., (1S,
4S,5S,6R,7S,8R,9R,11S), was deduced from the CD spectrum, in which a negative Cotton
effect was observed at 310 nm (Δε−12).10 Compound 3 was named songaricalarin C.
The HRESIMS of 4 showed a [M+Na]+ signal at m/z 451.2456, in accordance with the
molecular formula, C26H36O5Na. Comparing the NMR spectra of 4 (Tables 1 and 2) with
those of the known compound 65 showed that an isopropyl group in 6 was replaced by an
isopropylene group [δH 4.86, 4.92 (each 1H, brs), 1.76 (3H, s); δC 146.7 (C),δC 112.8
(CH2), 19.1 (CH3)] in 4. The relative configuration of 4 was assigned by analysis of
the 1H-1H coupling constants and ROESY correlations. When H-4 is assumed to be in a β–
orientation, H-9 and H-1 should be α-oriented due to the large 3J4,9 (10.5 Hz) and
small 3J1,9 (4.3 Hz) coupling constants respectively. Clear ROESY correlations of H-4 with
H-13 and of H-4 with H-7 indicated that the orientations of H-5 and H-7 should be α and β,
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respectively. Since the absolute configurations of 1–3 had already been established, it was
assumed that this configuration is also retained in their close congener 4 (songaricalarin D).
The molecular formula of 5 was determined as C28H40O8 by HRESIMS (m/z 527.2624 [M
+Na]+). The NMR spectra of 5 (Tables 1 and 2) were compared with those of the known
compound 7,6 and it was evident that a 4-acetoxy-4-methylsenecioyloxy group in 7 was
replaced by a 4-methylsenecioyloxy group [δH 5.63 (1H, brs), 2.15 (2H, q, J = 7.0 Hz), 1.06
(3H, t, J = 7.0 Hz), 2.11 (3H, s); δC 165.3 (CO), 113.8 (CH), 163.1 (C), 33.7 (CH2), 11.7
(CH3), 18.8 (CH3)] in 5. This postulate was confirmed by a significant ESIMS base peak at
m/z 390 [M–MesenOH]+. The positions of the three ester groups, located at C-14, C-6, and
C-7, were inferred from the HMBC correlations between H-14, H-6, and H-7 (δH 5.12, 5.15,
5.78, respectively) with the ester C=O resonances at δC 170.7, 176.0, and 165.3 of the OAc,
OMebu, and OMesen groups, respectively. Compound 5 with a specific optical rotation of
 (c 2.2, MeOH) is similar to compound 7 with a value of  (c 3.0,
CHCl3),6 and thus, they have the same relative and absolute configurations. Compound 5
was named songaricalarin E.
All isolates were evaluated for in vitro cytotoxicity against human lung carcinoma (A-549),
human breast adenocarcinoma (MCF-7), epidermoid carcinoma of the nasopharynx (KB),
and vincristine-resistant nasopharyngeal (KBVIN) cell lines according to a previously
described procedure.13 The results are given in Table 3. Compound 4 exhibited the highest
potency against all four cancer cell lines with EC50 values of 4.9, 0.8, 3.4, and 3.2 µg/mL,
respectively. Compounds 3–7 with a keto group at C-2 showed higher cytotoxicity against
the four cancer cell lines used, compared with compounds 1 and 2 without a keto group at
C-2, which were inactive or weakly active. This finding suggests that the keto group at C-2
might be important in mediating the cytotoxicity of oplopane sesquiterpenes. In addition,
compound 3, in which chlorine and hydroxy groups were added across the C8, C10 double
bond, was less potent against the A-549 and MCF-7 than against the two KB cell lines. This
result suggests that a chlorine atom might result in differential sensitivity between cell lines,
or that the double bond might be involved.
EXPERIMENTAL SECTION
General Experimental Procedures
Melting points were measured on an XT-4 micro-melting point apparatus and are
uncorrected. Optical rotations were recorded on a JASCO P-1020 polarimeter at room
temperature. UV spectra were measured on a Shimadzu UV-260 spectrophotometer in
absolute MeOH. IR spectra were recorded on an Avatar 360 FT-IR ESP spectrometer in
CH2Cl2. CD Spectra were recorded on a JASCO J-715 spectropolarimeter [γ([θ]) in nm].
NMR spectra were recorded on a Bruker DRX-400 spectrometer (400 MHz for 1H and 100
MHz for 13C). Mass spectra were determined on an HP5989A mass spectrometer for EIMS
and a Bruker Daltonics APEXIII 7.0 TESLA FTMS mass spectrometer for HRESIMS.
Analytical and preparative TLC were run on silica gel plates (GF254, Yantai Institute of
Chemical Technology, Yantai, People’s Republic of China). Spots were observed under UV
light and visualized by spraying with 10% H2SO4, followed by heating. Column
chromatography was performed on silica gel (200–300 mesh and 300–400 mesh; Qingdao
Marine Chemical Factory, Qingdao, People’s Republic of China) and Lichroprep RP18 gel
(40–60 µm, Merck, Darmstadt, Germany). X-ray crystallographic analysis was carried out
on a Bruker Smart Apex CCD diffractometer with graphite-monochromated Mo Kα
radiation (γ0.71073 Å).
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The roots and rhizomes of L. songarica were collected in August 2008 in the Tianshan
Mountains (altitude 550 m) in Xinjiang, People’s Republic of China. The identity of the
plant material was verified by Professor Ping Yan at Shihezi University and a voucher
specimen (DFC-WQ-LS-08-2) has been deposited in the Herbarium of Materia Medica,
Department of Pharmacognosy, School of Pharmacy, Fudan University, Shanghai, People’s
Republic of China.
Extraction and Isolation
The dried and powdered material (7.3 kg) was extracted three times with 95% EtOH at
reflux temperature and filtered. The filtrate was evaporated in vacuo to give a residue (560
g), a portion of which (500 g) was suspended in H2O (2 L) and partitioned successively with
petroleum ether (60–90 °C, 3×1.5 L) and EtOAc (3×1.5 L). The combined EtOAc (40 g) and
petroleum ether (340 g) extracts were chromatographed on Si gel (200–300 mesh, 2 kg,
10×120 cm) column, eluted successively with petroleum ether-acetone (50:1, 30:1, 15:1,
9:1, 7:1, 5:1, 3:1, 2:1, 1:1) to yield fractions 1–8. Fraction 4 (20 g) was applied to silica gel
CC with petroleum ether-EtOAc (7:1) to give three subfractions 4a, 4b, and 4c. Subfraction
4a (3 g) was applied to silica gel CC with petroleum ether-EtOAc (7:1) to afford 5 (46 mg),
subfraction 4b (2 g) was applied to silica gel CC with petroleum ether-acetone (7:1) to
afford 1 (36 mg), and subfraction 4c (6 g) was chromatographed similarly, followed by CC
on C18 RP gel with MeOH-H2O (4:1) to give 7 (76 mg). Fraction 5 (18 g) was applied to
silica gel CC with petroleum ether-EtOAc (6:1) to give two subfractions, 5a and 5b.
Subfraction 5a (5 g) was applied to silica gel CC with petroleum ether-EtOAc (6:1) to give 6
(77 mg), and subfraction 5b (6 g) was applied to silica gel CC with petroleum ether-EtOAc
(6:1), followed by prep TLC with petroleum ether-acetone (20:1) to give 4 (11 mg). Fraction
7 (26 g) was applied to silica gel CC with petroleum ether-acetone (5:1) to give two
subfractions, 7a and 7b. Subfraction 7a (5 g) was applied to silica gel CC with petroleum
ether-EtOAc (4:1) to give 3 (12 mg), and subfraction 7b (6 g) was applied to silica gel CC
with petroleum ether-EtOAc (4:1), followed by preparative TLC with CHCl3-acetone (20:1)




1)—colorless plates (acetone); mp 102–103 °C;  (c 0.1, CHCl3); IR (KBr) υmax
3485, 2972, 1712, 1646, 1375, 1246, 1148, 873, 751 cm−1; CD (c 0.05, MeOH) Δε250 +27,
Δε358 −22; for 1H NMR and 13C NMR spectroscopic data, see Tables 1 and 2, respectively;
EIMS m/z (%) 408 (2.7), 390 (1.1), 348 (4.1), 330 (1.2), 306 (1.7), 246 (5.4), 97 (100);
HRESIMS m/z 545.2725 [M+Na]+ (calcd C28H42O9Na, 545.2721);
Crystal data:14 C28H42O9, Mr = 522.62, monoclinic, space group P 21, a = 6.3820 (13) Å, b
= 14.364 (3) Å, β = 101.352 (3) °, c = 15.810 (3) Å, V = 1421.0 (5) Å3, Z = 2, Dcalc = 1.221




methylpent-2-enoate (Songaricalarin B, 2)—colorless gum;  (c 0.3,
CHCl3); CD (c 0.05, MeOH) Δε225 +13, Δε357 −12; IR (CH2Cl2) υmax 3467, 2969, 1736,
1648, 1368, 1251, 1144, 1081, 735 cm−1; for 1H NMR and 13C NMR spectroscopic data,
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see Tables 1 and 2, respectively; EIMS m/z (%) 350 (2.3), 290 (4.4), 230 (9.4), 212 (4.9),
173 (12), 97 (100); HRESIMS m/z 487.2457 [M+Na]+ (calcd C25H36O8Na, 487.2454).
(3S,3aR,4R,5S,6R,7S,7aS)-1-(1-Ethylidene)octahydro-3,6-bis[(2-
methylbutanoyl)oxy]-4-chloromethyl-4-hydroxy-7-[(2S)-2-methyloxiran-2-yl]-2-
oxo-1H-inden-5-yl(2E)-3-methylpent-2-enoate (Songaricalarin C, 3)—colorless
gum;  (c 0.12, CHCl3); CD (c 0.05, MeOH) Δε224 −14, Δε250 +14, Δε310 −12;
IR (CH2Cl2) υmax 3443, 2970, 1731, 1644, 1461, 1133, 737 cm−1; for 1H NMR and 13C
NMR spectroscopic data, see Tables 1 and 2, respectively; EIMS m/z (%) 596 (0.7), 278
(1.5), 231 (1.0) , 229 (2.4), 203 (0.8), 201 (2.2), 173 (1.6), 157 (1.5), 97 (100); HRESIMS
m/z 619.2651 [M+Na]+ (calcd C31H45O9ClNa, 619.2644).
(3S,3aR,5S,7S,7aS)-1-(1-Ethylidene)octahydro-3-[(2-methylbutanoyl)oxy]-4-
methylidene-7-propylene-2-oxo-1H-inden-5-yl(2E)-3-methylpent-2-enoate
(Songaricalarin D, 4)—colorless gum;  2 (c 1.1, MeOH); IR (CH2Cl2) υmax
2968, 1743, 1644, 1459, 1377, 1218, 1140, 997 cm−1; for 1H NMR (CDCl3) and 13C NMR
(CDCl3) spectroscopic data, see Tables 1 and 2, respectively; HRESIMS m/z 451.2456 [M
+Na]+ (calcd C26H36O5Na, 451.2455).
(1S,3aR,5S,6R,7S,7aR)-1-(1α-Acetoxyethyl)octahydro-6-[(2-
methylbutanoyl)oxy]-4-methylidene-7-[(2S)-2-methyloxiran-2-yl]-2-oxo-1H-
inden-5-yl(2E)-3-methylpent-2-enoate (Songaricalarin E, 5)—colorless gum;
 (c 2.2, MeOH); IR (CH2Cl2) υmax 3466, 2970, 1724, 1647, 1460, 1374,1244,
1141, 1037 cm−1; for 1H NMR and 13C NMR spectroscopic data, see Tables 1 and 2,
respectively; HRESIMS m/z 527.2624 [M+Na]+ (calcd C28H40O8Na, 527.2615).
Growth Inhibition Assays
Drug stock solutions were prepared in DMSO and stored at −70 °C. Upon dilution into
culture medium, the final DMSO concentration was ≤1% DMSO (v/v), a concentration
without effect on cell replication. The human tumor cell line panel consisted of lung
carcinoma (A-549), breast adenocarcinoma (MCF-7), epidermoid carcinoma of the
nasopharynx (KB), and vincristine-resistant nasopharyngeal (KBVIN). Etoposide was used
as a positive control. Cell culture and other procedures were the same as those reported
previously.13 The EC50 value is the concentration that inhibited growth by 50% following
two days of continuous exposure.
X-ray Crystallography
The structure was solved by direct methods using the program SHELXS, then refined by
SHELXS, with refinement of F2 against all reflections. All esds (except the esd in the
dihedral angle between two l.s. planes) are estimated using the full covariance matrix. Non-
hydrogen atoms were refined anisotropically. Hydrogen atoms were located by geometry
and riding on the related atoms during refinements with a temperature factor of 1.2 or 1.5
times the latter.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Key HMBC, 1H-1H COSY, and ROESY correlations of 1 and 3
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X-ray crystal structure of 1
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Table 1
1H NMR (400 MHz) Data of Compounds 1–5
1 a 2 b 3 b 4 b 5 b
1 4.33 dd, (3.4, 3.9) 1.66 m 5.28 d, (4.7) 5.53 d, (4.3) 2.15 dd, (15.2, 11.4)
- 2.11 m - - 2.44 dd, (15.2, 6.6)
2 5.25 dd, (3.4, 3.9) 5.50 m - - -
3 2.69 ddd, (10.2, 4.3, 3.9) 2.59 ddd, (10.0, 3.9, 3.9) - - 2.63 dd, (11.4, 3.6)
4 2.03 ddd, (12.6, 12.6, 10.2) 1.38 ddd, (11.0, 11.0, 10.0) 3.01 dd, (11.9, 11.9) 2.78 dd, (10.5, 10.2) 1.53 ddd, (11.4, 11.4, 11.4)
5 1.54 dd, (12.6, 10.2) 1.47 dd, (11.0, 10.5) 2.14 dd, (11.9, 11.9) 2.65 (1H, m) 2.00 dd, (11.4, 10.2)
6 3.76 dd, (10.2, 2.9) 3.83 dd, (10.5, 3.5) 5.45 dd, (11.9, 3.1) 1.78, 1.98 (m) 5.15 dd, (10.2, 3.6)
7 5.48 d, (2.9) 5.57 d, (3.5) 5.39 d, (3.1) 5.50 dd, (2.7, 3.1) 5.78 d, (3.6)
8 - - - - -
9 2.38 brd, (12.6) 2.24 m 2.05 dd, (11.9, 4.7) 2.62 dd, (10.5, 4.3) 2.63 ddd, (11.4, 10.2, 6.6)
10 5.19 brs 4.92 brs 3.55 d, (11.9) 4.83 brs 4.90, brs
5.30 brs 5.22 brs 3.92 d, (11.9) 5.30 brs 5.28, brs
11 - - - - -
12 2.65 d, (3.9) 2.79 d, (3.5) 2.59 d, (4.4) 4.86, brs 2.68 d, (3.9)
2.80 d, (3.9) 2.81 d, (3.5) 2.81 d, (4.4) 4.92, brs 2.80 d, (3.9)
13 1.32 s 1.33 s 1.48 s 1.76 s 1.22 s
14 5.17 dq, (6.8, 4.3) 5.11 dq, (6.6, 3.9) 6.50 dq, (7.4, 2.7) 6.43 dq, (7.4, 2.3) 5.12 dq, (6.6, 3.6)
15 1.48 d, (6.8) 1.45 d, (6.6) 2.22 d, (7.4) 2.12 d, (7.4) 1.23 d, (6.6)
OH 3.37 at C(1);
4.11 at C(6)
2.60 at C(8)
AcO : 1.91 s AcO: 1.99 s MebuO: AcO: 2.10 s
MebuO: AcO: 2.09 s (two groups) MebuO: MebuO:
2' 2.45 m 2' 2.36 m; 2.33 m 2' 2.40 m 2' 2.40 m
3' 1.52 m 3' 1.65 m; 1.46 m 3' 1.45 m 3' 1.47 m
    1.84 m     1.70 m; 1.69 m     1.66 m     1.75 m
4' 0.93 t, (7.3) 4' 0.89; 0.88 t, (7.4) 4' 0.88 t, (7.4) 4' 0.89 t, (7.8)
5' 1.18 d, (7.3) 5' 1.12; 1.15 d, (7.0) 5' 1.13 d, (7.0) 5' 1.15 d, (6.6)
MesenO: MesenO: MesenO: MesenO: MesenO:
2' 5.66 brs 2' 5.63 brs 2' 5.62 brs 2' 5.64 brs 2' 5.63 brs
4' 2.15 q, (7.3) 4' 2.15 q, (7.4) 4' 2.20 q, (7.0) 4' 2.17 q, (7.4) 4' 2.15 q, (7.0)
5' 1.02 t, (7.3) 5' 1.07 t, (7.4) 5' 1.08 t, (7.0) 5' 1.07 t, (7.4) 5' 1.06 t, (7.0)
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Table 3
Cytotoxicity Data of Compounds 1–7
EC50 (µg/mL)
compound
A549 MCF-7 KB KBVIN
1 >20 10.4 17.4 10.4
2 >20 >20 >20 >20
3 10.6 12.1 4.7 3.7
4 5.0 0.8 3.4 3.2
5 6.2 5.3 4.9 5.7
6 5.2 4.0 4.3 3.3
7 3.6 4.6 4.7 4.9
etoposide 0.4 16.4 3.9 8.8
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